Background
==========

Bone is the organ of the skeletal system and plays irreplaceable functions in shaping the body, mechanically supporting and protecting the body, and promoting movement \[[@b1-medscimonit-26-e919309]\]. In addition, bones contribute to the balance of mineral ions and regulate metabolism \[[@b2-medscimonit-26-e919309],[@b3-medscimonit-26-e919309]\]. The diverse functions of bones depend on the maintenance of bone homeostasis. Human bone marrow mesenchymal stem cells (hBMSCs) are compatible implants in bone tissue project and have a variety of properties that can be differentiated into osteoblasts, nerve cells, chondrocytes, and cardiomyocytes \[[@b4-medscimonit-26-e919309],[@b5-medscimonit-26-e919309]\]. Osteoblast differentiation is a vital process in maintaining bone homeostasis \[[@b6-medscimonit-26-e919309]\]. Hence, exploring the mechanisms involved in osteoblast differentiation of hBMSCs is of incredible value in bone homeostasis.

Zingerone, 4-(4-hydroxy-3-methoxyphenyl)-2-butanone (ZG) is a non-volatile compound produced directly during the drying of ginger. It has been reported that ZG has positive effects on human health including inhibiting tumor growth \[[@b7-medscimonit-26-e919309]\], anti-inflammatory \[[@b8-medscimonit-26-e919309]\], and antioxidant \[[@b9-medscimonit-26-e919309]\] effects against radiation-induced genetic damage and apoptosis \[[@b10-medscimonit-26-e919309]\]. However, the research on ZG on osteogenic differentiation is extremely limited. Srinaath et al. reported that ZG had a stimulatory action on the differentiation of mouse mesenchymal stem cells (mMSCs) towards osteoblasts, suggesting its unique role in bone tissue regeneration \[[@b11-medscimonit-26-e919309]\].

The microRNAs (miRNAs) are single-stranded, noncoding RNAs that are 18\~22 nucleotide in length, and which function through competitively combining with the 3′-untranslated region (3′UTR) of target mRNAs \[[@b12-medscimonit-26-e919309]\]. Interestingly, recent research has hinted the capacity of certain miRNAs to conduct differentiation and behavior in the microenvironment of bone tissues. For example, overexpression of miR-96 promoted osteoblast differentiation and bone formation via exciting Wnt signaling pathway in ankylosing spondylitis (AS) mice \[[@b13-medscimonit-26-e919309]\]. Overexpression of miR-214 inhibited the osteoblast differentiation of BMSCs through suppressing β-catenin expression and attenuating Wnt/β-catenin signaling pathway activity \[[@b14-medscimonit-26-e919309]\]. MiR-33a-5p contributed to tumor necrosis factor-α (TNF-α)-inhibited osteogenic differentiation through downregulating the level of special AT-rich sequence-binding protein 2 (SATB2) in hBMSCs \[[@b15-medscimonit-26-e919309]\]. These findings revealed the essential roles of miRNAs in the processes of osteoblast differentiation and bone formation. Previous reports noticed the aberrant downregulation of miR-200c-3p in cemento-ossifying fibroma (COF) \[[@b16-medscimonit-26-e919309]\], and the role of miR-200c in osteogenic differentiation has been mentioned a lot \[[@b17-medscimonit-26-e919309],[@b18-medscimonit-26-e919309]\]. However, the role of miR-200c-3p in hBMSCs and associated mechanism in osteogenic differentiation is still not clear.

Recently, smad7 has been identified to inhibit transforming growth factor β (TGF-β) signals transduction by acting downstream of TGF-βreceptor \[[@b19-medscimonit-26-e919309]\]. The role of smad7 in TGF-β-mediated physiology and pathology is diverse. For instance, smad7 has been shown to function in the processes of tumorigenesis, metastasis and invasion of colorectal cancer \[[@b20-medscimonit-26-e919309]\], human breast cancer \[[@b21-medscimonit-26-e919309]\], melanoma \[[@b22-medscimonit-26-e919309]\] and endometrial carcinomas \[[@b23-medscimonit-26-e919309]\]. Smad7 could also mediate the inflammatory response and autoimmune inflammation of TGF-β in some situations, such as inflammatory bowel disease \[[@b24-medscimonit-26-e919309],[@b25-medscimonit-26-e919309]\]. Additionally, the involvement of smad7 in osteogenic differentiation was partly identified \[[@b26-medscimonit-26-e919309],[@b27-medscimonit-26-e919309]\]. Unfortunately, the role of smad7 in osteogenic differentiation and regulatory mechanism were still limited and needed further investigation.

In our present study, we aimed to verify the impact of ZG on osteoblast differentiation and the expression levels of miR-200c-3p and smad7 in ZG-induced hBMSCs. Moreover, we detected the relationship between miR-200c-3p and smad7, and their functional roles in ZG-induced hBMSCs, aiming to provide an underlying mechanism of ZG in the process of osteoblast differentiation.

Material and Methods
====================

Cell culture and cell treatment
-------------------------------

The hBMSCs were isolated as described in a previous study \[[@b28-medscimonit-26-e919309]\] and were maintained in Dulbecco's Modified Eagle Medium (DMEM; Life Technologies, Grand Island, NY, USA) supplemented with 10% fetal bovine serum (FBS; Life Technologies) at 37°C in a humidified atmosphere of 5% CO~2~ and 95% air.

Osteogenesis was induced by ZG (Sigma-Aldrich, St. Louis, MO, USA) according to the previous description \[[@b11-medscimonit-26-e919309]\]. Briefly, hBMSCs were treated with ZG at concentrations of 50 μM, 100 μM, and 200 μM for 48 hours, and the untreated group was considered as control. In addition, hBMSCs were treated with 200 μM ZG at different stages (0, 24, 48, and 72 hours) for time-course analysis. For functional analysis, hBMSCs were treated with 200 μM ZG for further investigation.

Cell transfection
-----------------

MiR-200c-3p mimics (miR-200c-3p) and miR-200c-3p inhibitor (in-miR-200c-3p) together with their corresponding negative control (miR-NC and in-miR-NC) were purchased from Ribobio (Guangzhou, China). Overexpression vector of smad7 pcDNA3.1-smad7 (smad7) was constructed by Hanbio Biotechnology Co., Ltd. (Shanghai, China). All transfection reactions in hBMSCs were conducted by using Lipofectamine 2000 reagent (Thermo Fisher Scientific, Waltham, MA, USA). Following experiments were performed at 48 hours post-transfection.

3-(4,5-dimethyl-2-thiazolyl)-2, 5-diphenyl-2-H-tetrazolium bromide (MTT) assay
------------------------------------------------------------------------------

MTT assay was conducted to check the cytotoxicity of ZG as described by previous research \[[@b29-medscimonit-26-e919309]\]. Specifically, hBMSCs treated with ZG were cultured in DMEM in 24-well plates for 48 hours. Then the supernatant was obtained by centrifugation and then 200 μL of 0.05% MTT solution (Beyotime, Shanghai, China) was sucked in every well. After incubating for continuing 1 hour at room temperature, the upper solution was discarded, and dimethyl sulfoxide (DMSO; Sigma-Aldrich) was used to dissolve the formazan crystal in each well. Finally, the optical density (OD) value at 570 nm was recorded by using spectrophotometer (Thermo Fisher Scientific).

Quantitative real-time polymerase chain reaction (qRT-PCR)
----------------------------------------------------------

Total RNA was isolated from hBMSCs treated with ZG at different concentrations or at different time points using TRIzol reagent (Sigma-Aldrich). For miR-200c-3p quantification, TaqMan MicroRNA Reverse Transcription Kit (Applied Biosystems, Carlsbad, CA, USA) was used to conduct reverse transcription reaction. For smad7 quantification, cDNA synthesis was done with High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems). Then the qRT-PCR reaction was performed with the Power SYBR Green PCR Master Mix (Applied Biosystems) on 7900HT thermocycler (Applied Biosystems). The relative expression was calculated by using the 2^−ΔΔCt^ method. U6 small nucleolar RNA and β-actin were used as internal controls. Primers were listed as below:

1.  alkaline phosphatase (ALP),

2.  forward (F): 5′-TTGTGCCAGAGAAAGAGAGAGA-3′ and

3.  reverse (R): 5′-GTTTCAGGGCATTTTTCAAGGT-3′;

4.  osteocalcin (OC), F: 5′-ATGGCTTGAAGACCGCCTAC-3′ and

5.  R: 5′-AGGGCAGAGAGAGAGGACAG-3′;

6.  osterix (OSX), F: 5′-ACTGGCTAGGTGGTGGTCAG-3′ and

7.  R: 5′-GGTAGGGAGCTGGGTTAAGG-3′;

8.  runt-related transcription factor 2 (RUNX2),

9.  F: 5′-AGATGATGACACTGCCACCTCTG-3′

10. and R: 5′-GGGATGAAATGCTTGGGAACTGC-3′;

11. β-actin, F: 5′-GCACCACACCTTCTACAATG-3′ and

12. R: 5′-TGCTTGCTGATCCACATCTG-3′; U6,

13. F: 5′-CGCTTCGGCAGCACATATAC-3′ and

14. R: 5′-TTCACGAATTTGCGTGTCAT-3′.

The primers of miR-200c-3p were directly purchased from Ribobio (Guangzhou).

Western blot assay
------------------

RIPA lysis buffer (Bio Basic, Markham, Ontario, Canada) was used to obtain total protein from hBMSCs. Next, total protein was separated by 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) after detecting the concentration and then transferred on polyvinylidene fluoride (PVDF) membranes (Bio-Rad, Hercules, California, USA). Afterwards, the membranes were blocked at room temperature by tris-buffered saline (TBS; Sigma-Aldrich) containing 5% skim milk for 2 hours and incubated with the primary antibodies against ALP (ab83259, 1: 1000; Abcam, Cambridge, UK), OC (ab93876, 1: 500; Abcam), OSX (ab22552, 1: 1000; Abcam), RUNX2 (ab23981, 1: 1000; Abcam), smad7 (ab90086, 1: 1000; Abcam), or β-actin (ab8226, 1: 1000; Abcam). Next day, the membranes were washed and incubated with horseradish peroxidase (HRP)-conjugated secondary antibody (ab205718, 1: 5000; Abcam) for 2 hours. Finally, the blots were visualized using an enhanced chemiluminescence (ECL) kit (Millipore, Billerica, MA, USA) on the ECL detection system (Millipore).

MiRNA target sites prediction
-----------------------------

The target genes and binding sites of miR-200c-3p were identified through the online bioinformatics analysis tool TargetScan (*<http://www.targetscan.org>*).

Luciferase reporter assay
-------------------------

Smad7 3′UTR wild type (smad7 3′UTR-WT) sequences containing the binding sites of miR-200c-3p and smad7 3′UTR mutant (smad7 3′UTR-MUT) sequences designed by smad7 3′UTR-WT were amplified and inserted into the pGL3-basic vector. Then smad7 3′-UTR-WT or smad7 3′-UTR-MUT and miR-200c-3p or in-miR-200c-3p were co-transfected into hBMSCs, respectively, miR-NC and in-miR-NC acting as controls. After 48-hour transfection, cell lysates were collected, and luciferase activity was measured by using the Dual-Luciferase Reporter Assay System (Promega, Madison, WI, USA) on a FLUOstar Omega (BMG Labtech, Ortenberg, Germany).

RNA immunoprecipitation (RIP) assay
-----------------------------------

Magna RIPTM RNA-Binding Protein Immunoprecipitation Kit (Millipore) was adopted to carry out RIP assay in agreement with the manufacturer's instructions. Specifically, hBMSCs were lysed with RIP lysis solution. Then cell lysate was disposed of RIP buffer containing magnetic beads conjugated to human anti-AGO2 antibody or IgG control. The co-precipitated RNAs were purified and quantified by qRT-PCR.

Statistical analysis
--------------------

Statistical analysis was operated using SPSS 15.0 software (SPSS, Chicago, IL, USA). All data are presented as mean±standard deviation (SD) based on the results of at least 3 independent experiment. Differences were analyzed using Student's *t*-test to compare 2 groups or one-way ANOVA for multiple groups. The difference (*P*\<0.05) was considered to be statistically significant.

Results
=======

ZG was non-toxic nature and promoted osteoblast differentiation in hBMSCs
-------------------------------------------------------------------------

To determine the effects on osteoblast differentiation of ZG, hBMSCs were treated with ZG of 200 μM for 48 hours, and then typical osteoblast differentiation markers, such as ALP, OC, OSX, and RUNX2, were quantified by qRT-PCR and western blot assay. The chemical structural formula of ZG was shown in [Figure 1A](#f1-medscimonit-26-e919309){ref-type="fig"}. Beforehand, the cytotoxicity of ZG to hBMSCs was checked. The results showed that cells treated with ZG at a concentration of 50 μM, 100 μM, or 200 μM had no obvious change in OD value compared with control ([Figure 1B](#f1-medscimonit-26-e919309){ref-type="fig"}). Besides, the cells treated with 200 μM for 24, 48, and 72 hours had no significant change in OD value ([Figure 1C](#f1-medscimonit-26-e919309){ref-type="fig"}). These data suggested that ZG was a non-toxic nature to hBMSCs. Furthermore, the expression of ALP, OC, OSX, and RUNX2 was congruously promoted at both mRNA ([Figure 1D](#f1-medscimonit-26-e919309){ref-type="fig"}) and protein ([Figure 1E](#f1-medscimonit-26-e919309){ref-type="fig"}) levels in hBMSCs treated with ZG. The data suggested that osteoblast differentiation was promoted under ZG treatment conditions.

MiR-200c-3p was upregulated, but smad7 was downregulated in ZG-induced hBMSCs at different concentration for different stages
-----------------------------------------------------------------------------------------------------------------------------

To detect the effect of ZG on the expression of miR-200c-3p and smad7 in hBMSCs, qRT-PCR or western blot was performed. The expression of miR-200c-3p was significantly increased in hBMSCs treated with ZG (50 μM, 100 μM, and 200 μM) following the dose-dependent manner compared with control ([Figure 2A](#f2-medscimonit-26-e919309){ref-type="fig"}). Besides, the expression of miR-200c-3p was increasingly strengthened with the increase of time (24, 48, and 72 hours) after treatment with 200 μM ZG compared with untreated cells ([Figure 2B](#f2-medscimonit-26-e919309){ref-type="fig"}). On the contrary, the protein level of smad7 was gradually reduced with the enrichment of ZG concentration ([Figure 2C](#f2-medscimonit-26-e919309){ref-type="fig"}). Similarly, the level of smad7 was declined inch by inch with the increase of time ([Figure 2D](#f2-medscimonit-26-e919309){ref-type="fig"}). These data claimed that miR-200c-3p and smad7 might partly function ZG-induced hBMSCs.

MiR-200c-3p contributed to osteoblast differentiation in ZG-induced hBMSCs
--------------------------------------------------------------------------

To verify the role of miR-200c-3p on osteoblast differentiation, ZG-induced hBMSCs were transfected with miR-200c-3p or in-miR-200c-3p, miR-NC or in-miR-NC as the control. Firstly, the efficiency of miR-200c-3p overexpression or inhibition was examined and the result showed that the expression of miR-200c-3p was rapidly picked up in ZG-induced cells transfected with miR-200c-3p compared with miR-NC, while the expression of miR-200c-3p was rapidly plummeted in cells treated with in-miR-200c-3p ([Figure 3A](#f3-medscimonit-26-e919309){ref-type="fig"}). Next, the result of qRT-PCR indicated that the accumulation of miR-200c-3p facilitated the expression of ALP, OC, OSX, and RUNX2 compared with miR-NC ([Figure 3B](#f3-medscimonit-26-e919309){ref-type="fig"}). Not surprisingly, the inhibition of miR-200c-3p sequestered the expression of ALP, OC, OSX, and RUNX2 ([Figure 3B](#f3-medscimonit-26-e919309){ref-type="fig"}). Simultaneously, the protein levels of ALP, OC, OSX and RUNX2 assessed by western blot revealed the coincident result with their mRNA levels assessed by qRT-PCR ([Figure 3C](#f3-medscimonit-26-e919309){ref-type="fig"}). This data implied that miR-200c-3p played an active role in the process of osteoblast differentiation.

Smad7 was a target of miR-200c-3p
---------------------------------

To ascertain the interaction between miR-200c-3p and smad7, online software TargetScan was used to analyze the binding sites between miR-200c-3p and smad7. The binding sites between miR-200c-3p and smad7 3′ UTR were exhibited in [Figure 4A](#f4-medscimonit-26-e919309){ref-type="fig"}, then the wild type sequences of smad7 3′ UTR (smad7 3′UTR-WT) containing the binding sites with miR-200c-3p were mutated to generate smad7 3′UTR mutant sequences (smad7 3′UTR-MUT). Afterwards, smad7 3′UTR-WT and smad7 3′UTR-MUT were amplified and cloned into pGL3-basic vector to construct fusion plasmids, namely smad7 3′-UTR-WT and 3′-UTR-MUT, respectively. Luciferase reporter assay showed that the luciferase activity was remarkably decreased in cells co-transfected with smad7 3′-UTR-WT and miR-200c-3p, while there was no significant change in luciferase activity of cells co-transfected with smad7 3′-UTR-MUT and miR-200c-3p, miR-NC as a control ([Figure 4B](#f4-medscimonit-26-e919309){ref-type="fig"}). Inversely, luciferase activity was obviously enhanced in cells co-transfected with smad7 3′-UTR-WT and in-miR-200c-3p, while luciferase activity had no noticeable change in cells co-transfected with smad7 3′-UTR-MUT and in-miR-200c-3p, in-miR-NC as a control ([Figure 4C](#f4-medscimonit-26-e919309){ref-type="fig"}). Synchronously, RIP assay observed that miR-200c-3p mimics could reinforce the enrichment of smad7 in Ago2 RIP compared with miR-NC, whereas there was no difference of smad7 expression in IgG RIP ([Figure 4D](#f4-medscimonit-26-e919309){ref-type="fig"}). Moreover, western blot analysis proved that the expression of smad7 was significantly diminished in cells transfected with miR-200c-3p, while it was sharply intensified in cells transfected with in-miR-200c-3p, miR-NC or in-miR-NC acting as the control ([Figure 4E](#f4-medscimonit-26-e919309){ref-type="fig"}). This data manifested that miR-200c-3p regulated smad7 expression by directly binding to smad7.

MiR-200c-3p promoted the expression of ALP, OC, OSX, and RUNX2 through downregulating smad7 in ZG-induced hBMSCs
----------------------------------------------------------------------------------------------------------------

To elucidate the underlying mechanism of miR-200c-3p regulating osteoblast differentiation in ZG-induced hBMSCs, miR-200c-3p, miR-NC, miR-200c-3p +smad7, and miR-200c-3p+pcDNA was transfected into ZG-induced hBMSCs, respectively. First, western blot analysis showed that the transfection of miR-200c-3p+smad7 recovered the expression of smad7 inhibited by miR-200c-3p overexpression ([Figure 5A](#f5-medscimonit-26-e919309){ref-type="fig"}). The analysis of qRT-PCR suggested that overexpression of miR-200c-3p in hBMSCs resulted in the promotion of osteoblast differentiation markers (ALP, OC, OSX, and RUNX2). However, the simultaneous ectopic overexpression of smad7 reversed the accelerative effects of miR-200c-3p on the expression of osteoblast differentiation markers ([Figure 5B](#f5-medscimonit-26-e919309){ref-type="fig"}). The protein levels of these markers presented the uniform tendency with the mRNA expression level ([Figure 5C](#f5-medscimonit-26-e919309){ref-type="fig"}). These results indicated that miR-200c-3p promoted osteoblast differentiation in ZG-induced hBMSCs by inhibiting smad7 expression.

Discussion
==========

Osteoblast differentiation holds its value in the maintenance of bone homeostasis. ZG is a compound isolated from ginger and has positive effects on a variety of biological processes. This study evaluated the toxicity of ZG to hBMSCs and explored the effects of ZG treatment on the expression of osteoblast differentiation markers. The study also identified the significantly upregulated miR-200c-3p and significantly downregulated smad7 in ZG-induced cells and investigated their interrelationship and their roles on the expression of osteoblast differentiation markers in ZG-induced hBMSCs. This report revealed a possible mechanism for ZG to promote osteoblast differentiation in hBMSCs.

With the change of lifestyles and concepts, people are more inclined to use natural substances for disease treatment \[[@b30-medscimonit-26-e919309]\]. ZG is a natural compound separated from the drying process of ginger. As an immunostimulant, ZG has various biological functions, including anti-inflammatory activity, antioxidant activity, antidiarrhoeic, phagocytic activity and anti-pathogenic activity \[[@b30-medscimonit-26-e919309]--[@b33-medscimonit-26-e919309]\]. Particularly, ZG is positive and has a stimulating effect on the differentiation of mMSCs into osteoblasts at the cellular and molecular levels \[[@b11-medscimonit-26-e919309]\]. Similarly, our research suggested that ZG contributed to osteoblast differentiation by stimulating the expression osteoblast differentiation markers, including RUNX2, ALP, OSX, and OC. Runx2, expressed in osteoblast lineage cells and chondrocytes, has been reported as an inducer of osteoblast and chondrocyte differentiation \[[@b34-medscimonit-26-e919309]\]. Most of ALP isoenzymes are derived from the bones and liver \[[@b35-medscimonit-26-e919309]\]. ALP is regarded as a key marker for osteoblast activity during the early stage of osteoblast differentiation \[[@b36-medscimonit-26-e919309]\]. OSX, a zinc-finger-containing transcription factor, is necessary for bone formation and osteoblast differentiation \[[@b37-medscimonit-26-e919309],[@b38-medscimonit-26-e919309]\]. OC, also known as bone Gla protein, is the most affluent non-collagen in the bone. It was synthesized and secreted by mature osteoblasts and osteocytes and is currently served as a sign for bone formation \[[@b39-medscimonit-26-e919309],[@b40-medscimonit-26-e919309]\]. In agreement with the previous study, this paper elucidated the function of ZG to promote osteoblast differentiation, and this function was partly accomplished by reinforcing the expression of miR-200c-3p.

MiR-200c-3p is a member of miR-200c family. A recent study reported that overexpression of miR-200c promoted osteogenic differentiation by targeting Myd88 via activating the AKT/β-catenin signaling pathway \[[@b4-medscimonit-26-e919309]\]. Another research reported that miR-200c improved osteogenic differentiation through directly regulating IL-6, IL-8, and CCL-5 expression by binding to their 3′UTRs \[[@b41-medscimonit-26-e919309]\]. Consistent with these papers, our study demonstrated that miR-200c-3p mimics effectively promoted osteoblast differentiation via enhancing the expression of several osteoblast differentiation markers. Additionally, smad7, acting as a target of miR-200c-3p, was observed in this paper. Smad7 has been reported as a corepressor of Runx2 and inhibits osteoblast differentiation through acting as a target of certain miRNAs. According to the reports, miR-590-5p weakened the depleted effect of high glucose (HG) on osteoblast differentiation by inhibiting the abundance of smad7 in MC3T3-E1 osteoblastic cells \[[@b42-medscimonit-26-e919309]\]. Smad7 inhibited proliferation, differentiation and mineralization of mouse osteoblastic cells \[[@b43-medscimonit-26-e919309]\]. MiR-17-5p might modulate osteoblastic cell proliferation partly through suppressing SMAD7 expression \[[@b44-medscimonit-26-e919309]\]. These findings suggest that smad7 might serve as a negative factor in the process of osteoblast differentiation.

Conclusions
===========

Collectively, our study firstly indicated that ZG led to the facilitation of osteoblast differentiation via miR-200c-3p/smad7 regulatory axis, which provided a novel route for the stimulation of bone formation and regeneration.
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![ZG was non-toxic nature and promoted osteogenesis in hBMSCs. (**A**) The chemical structural formula of ZG was shown. (**B**) Cytotoxicity assessment was performed in hBMSCs treated with ZG at different concentrations (50 μM, 100 μM and 200 μM) by MTT assay. (**C**) Cytotoxicity detection of hBMSCs treated with 200 μM ZG at different stages (0, 24, 48, and 72 hour) was carried out by MTT assay. (**D, E**) The mRNA (**D**) and protein (**E**) expression levels of osteoblast differentiation markers (ALP, OC, OSX, and RUNX2) were measured by qRT-PCR or western blot in hBMSCs treated with ZG, respectively. Data were presented as mean±standard deviation (SD) based on 3 independent replicates. \* *P*\<0.05. ZG -- zingerone; hBMSCs -- human bone mesenchymal stem cells; MTT assay -- 3-(4,5-dimethyl-2-thiazolyl)-2, 5-diphenyl-2-H-tetrazolium bromide assay; qRT-PCR -- quantitative real-time polymerase chain reaction; ALP -- alkaline phosphatase; OC -- osteocalcin; OSX -- osterix; RUNX2 -- runt-related transcription factor 2.](medscimonit-26-e919309-g001){#f1-medscimonit-26-e919309}

![MiR-200c-3p was upregulated, but smad7 was downregulated in hBMSCs treated with ZG. (**A**) The expression of miR-200c-3p in hBMSCs treated with ZG at different concentrations (50 μM, 100 μM, and 200 μM) was assessed by qRT-PCR. (**B**) The expression of miR-200c-3p in hBMSCs treated with 200 μM ZG at different stages (0, 24, 48, and 72 hours) was assessed by qRT-PCR. (**C**) The expression of smad7 in hBMSCs treated with ZG at different concentrations (50 μM, 100 μM, and 200 μM) was quantified by western blot. (**D**) The expression of smad7 in hBMSCs treated with 200 μM ZG at the different stage (0, 24, 48, and 72 hours) was quantified by western blot. Data were presented as mean±standard deviation (SD) based on 3 independent replicates. \* *P*\<0.05. ZG -- zingerone; hBMSCs -- human bone mesenchymal stem cells; NC -- negative control; qRT-PCR -- quantitative real-time polymerase chain reaction.](medscimonit-26-e919309-g002){#f2-medscimonit-26-e919309}

![MiR-200c-3p contributed to osteoblast differentiation in ZG-induced hBMSCs. ZG-induced hBMSCs were transfected with miR-200c-3p mimics or miR-200c-3p inhibitor, miR-NC or in-miR-NC acting as a control. (**A**) The efficiency of miR-200c-3p overexpression or inhibition was measured by qRT-PCR. (**B, C**) The effects of miR-200c-3p overexpression or inhibition on the expression of osteoblast differentiation markers (ALP, OC, OSX, and RUNX2) were monitored by qRT-PCR (**B**) or western blot (**C**). Data were presented as mean±standard deviation (SD) based on 3 independent replicates. \* *P*\<0.05. ZG -- zingerone; hBMSCs -- human bone mesenchymal stem cells; NC -- negative control; qRT-PCR -- quantative real-time polymerase chain reaction; ALP -- alkaline phosphatase; OC -- osteocalcin; OSX -- osterix; RUNX2 -- runt-related transcription factor 2.](medscimonit-26-e919309-g003){#f3-medscimonit-26-e919309}

![(**A--E**) smad7 was a target of miR-200c-3p. (**A**) The binding sites between miR-200c-3p and smad7 were analyzed by online software TargetScan. (**B, C**) Luciferase reporter assay was executed to verify the interaction of miR-200c-3p and smad7 in hBMSCs. (**B**) hBMSCs were transfected with smad7 3′UTR-WT sequences containing binding sites of miR-200c-3p or smad7 3′UTR-MUT sequences and miR-200c-3p mimics, miR-NC as a control. (**C**) hBMSCs were transfected with smad7 3′UTR-WT sequences containing binding sites of miR-200c-3p or smad7 3′UTR-MUT sequences and miR-200c-3p inhibitor, in-miR-NC as a control. (**D**) RIP assay was conducted to further confirmed the relationship between miR-200c-3p and smad7. (**D**) The protein level of smad7 was determined by western blot assay after miR-200c-3p overexpression or inhibition. Data were presented as mean±standard deviation (SD) based on 3 independent replicates. \* *P*\<0.05. hBMSCs -- human bone mesenchymal stem cells; RIP -- RNA immunoprecipitation.](medscimonit-26-e919309-g004){#f4-medscimonit-26-e919309}

![MiR-200c-3p promoted osteoblast differentiation in ZG-induced hBMSCs by downregulating smad7 expression. hBMSCs treated with 200 μM ZG for 48 hours were transfected with miR-200c-3p mimics, NC, miR-200c-3p mimics+ pcDNA-smad7, or miR-200c-3p mimics+ pcDNA, respectively. (**A**) The relative protein level of smad7 was measured by western blot. (**B**) qRT-PCR was performed to detect changes in the mRNA levels of ALP, OC, OSX, and RUNX2. (**C**) The protein levels of ALP, OC, OSX, and RUNX2 were quantified by western blot analysis. Data were presented as mean±standard deviation (SD) based on 3 independent replicates. \* *P*\<0.05. ZG -- zingerone; hBMSCs -- human bone mesenchymal stem cells; NC -- negative control; qRT-PCR -- quantitative real-time polymerase chain reaction; ALP -- alkaline phosphatase; OC -- osteocalcin; OSX -- osterix; RUNX2 -- runt-related transcription factor 2.](medscimonit-26-e919309-g005){#f5-medscimonit-26-e919309}
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